Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 165

1.

Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme.

Amir E, Evans DG, Shenton A, Lalloo F, Moran A, Boggis C, Wilson M, Howell A.

J Med Genet. 2003 Nov;40(11):807-14.

PMID:
14627668
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Evaluation of mathematical models for breast cancer risk assessment in routine clinical use.

Fasching PA, Bani MR, Nestle-Krämling C, Goecke TO, Niederacher D, Beckmann MW, Lux MP.

Eur J Cancer Prev. 2007 Jun;16(3):216-24.

PMID:
17415092
[PubMed - indexed for MEDLINE]
3.

Differences and similarities in breast cancer risk assessment models in clinical practice: which model to choose?

Jacobi CE, de Bock GH, Siegerink B, van Asperen CJ.

Breast Cancer Res Treat. 2009 May;115(2):381-90. doi: 10.1007/s10549-008-0070-x. Epub 2008 May 30.

PMID:
18516672
[PubMed - indexed for MEDLINE]
4.

Evaluation of the Tyrer-Cuzick (International Breast Cancer Intervention Study) model for breast cancer risk prediction in women with atypical hyperplasia.

Boughey JC, Hartmann LC, Anderson SS, Degnim AC, Vierkant RA, Reynolds CA, Frost MH, Pankratz VS.

J Clin Oncol. 2010 Aug 1;28(22):3591-6. doi: 10.1200/JCO.2010.28.0784. Epub 2010 Jul 6.

PMID:
20606088
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Comparisons of two breast cancer risk estimates in women with a family history of breast cancer.

McTiernan A, Kuniyuki A, Yasui Y, Bowen D, Burke W, Culver JB, Anderson R, Durfy S.

Cancer Epidemiol Biomarkers Prev. 2001 Apr;10(4):333-8.

PMID:
11319173
[PubMed - indexed for MEDLINE]
Free Article
6.

Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention.

Rockhill B, Spiegelman D, Byrne C, Hunter DJ, Colditz GA.

J Natl Cancer Inst. 2001 Mar 7;93(5):358-66.

PMID:
11238697
[PubMed - indexed for MEDLINE]
Free Article
7.

Breast cancer risk assessment in 8,824 women attending a family history evaluation and screening programme.

Evans DG, Ingham S, Dawe S, Roberts L, Lalloo F, Brentnall AR, Stavrinos P, Howell A.

Fam Cancer. 2014 Jun;13(2):189-96. doi: 10.1007/s10689-013-9694-z.

PMID:
24276527
[PubMed - in process]
8.

Limitations of the Gail model in the specialized breast cancer risk assessment clinic.

Euhus DM, Leitch AM, Huth JF, Peters GN.

Breast J. 2002 Jan-Feb;8(1):23-7.

PMID:
11856157
[PubMed - indexed for MEDLINE]
9.

Understanding mathematical models for breast cancer risk assessment and counseling.

Euhus DM.

Breast J. 2001 Jul-Aug;7(4):224-32. Review.

PMID:
11678799
[PubMed - indexed for MEDLINE]
10.

Predicting risk of breast cancer in postmenopausal women by hormone receptor status.

Chlebowski RT, Anderson GL, Lane DS, Aragaki AK, Rohan T, Yasmeen S, Sarto G, Rosenberg CA, Hubbell FA; Women's Health Initiative Investigators.

J Natl Cancer Inst. 2007 Nov 21;99(22):1695-705. Epub 2007 Nov 13.

PMID:
18000216
[PubMed - indexed for MEDLINE]
Free Article
11.

[Models for risk assessment and prediction in breast cancer].

Hu Z, Li X, Feng MH, Chu JJ, Xie W.

Zhonghua Liu Xing Bing Xue Za Zhi. 2009 Oct;30(10):1073-7. Chinese.

PMID:
20193393
[PubMed - indexed for MEDLINE]
12.

Probability estimation models for prediction of BRCA1 and BRCA2 mutation carriers: COS compares favourably with other models.

Roudgari H, Miedzybrodzka ZH, Haites NE.

Fam Cancer. 2008;7(3):199-212. Epub 2007 Dec 21.

PMID:
18097771
[PubMed - indexed for MEDLINE]
13.

Validation of a tool for identifying women at high risk for hereditary breast cancer in population-based screening.

Hoskins KF, Zwaagstra A, Ranz M.

Cancer. 2006 Oct 15;107(8):1769-76.

PMID:
16967460
[PubMed - indexed for MEDLINE]
Free Article
14.

The effectiveness of the Gail model in estimating risk for development of breast cancer in women under 40 years of age.

MacKarem G, Roche CA, Hughes KS.

Breast J. 2001 Jan-Feb;7(1):34-9.

PMID:
11348413
[PubMed - indexed for MEDLINE]
15.

Mammographic breast density and the Gail model for breast cancer risk prediction in a screening population.

Tice JA, Cummings SR, Ziv E, Kerlikowske K.

Breast Cancer Res Treat. 2005 Nov;94(2):115-22.

PMID:
16261410
[PubMed - indexed for MEDLINE]
16.

Validation of a breast cancer risk assessment model in women with a positive family history.

Bondy ML, Lustbader ED, Halabi S, Ross E, Vogel VG.

J Natl Cancer Inst. 1994 Apr 20;86(8):620-5.

PMID:
8003106
[PubMed - indexed for MEDLINE]
17.

Breast cancer risk prediction with a log-incidence model: evaluation of accuracy.

Rockhill B, Byrne C, Rosner B, Louie MM, Colditz G.

J Clin Epidemiol. 2003 Sep;56(9):856-61.

PMID:
14505770
[PubMed - indexed for MEDLINE]
18.

Gail model risk factors: impact of adding an extended family history for breast cancer.

Crispo A, D'Aiuto G, De Marco M, Rinaldo M, Grimaldi M, Capasso I, Amore A, Bosetti C, La Vecchia C, Montella M.

Breast J. 2008 May-Jun;14(3):221-7. doi: 10.1111/j.1524-4741.2008.00566.x. Epub 2008 Mar 26.

PMID:
18373641
[PubMed - indexed for MEDLINE]
19.

Risk and risk assessment for breast cancer: molecular and clinical aspects.

Beckmann MW, Bani MR, Fasching PA, Strick R, Lux MP.

Maturitas. 2007 May 20;57(1):56-60. Epub 2007 Mar 26. Review.

PMID:
17386982
[PubMed - indexed for MEDLINE]
20.

Critical assessment of new risk factors for breast cancer: considerations for development of an improved risk prediction model.

Santen RJ, Boyd NF, Chlebowski RT, Cummings S, Cuzick J, Dowsett M, Easton D, Forbes JF, Key T, Hankinson SE, Howell A, Ingle J; Breast Cancer Prevention Collaborative Group.

Endocr Relat Cancer. 2007 Jun;14(2):169-87. Review.

PMID:
17639036
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk